サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513934

腎臓結石管理機器の世界市場

Kidney Stone Management Devices

出版日
ページ情報
英文 196 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
腎臓結石管理機器の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腎臓結石管理機器の世界市場は2030年までに23億米ドルに達する見込み

2023年に17億米ドルと推定される腎臓結石管理機器の世界市場は、分析期間2023-2030年にCAGR 4.8%で成長し、2030年には23億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである尿管鏡検査は、CAGR 5.4%を記録し、分析期間終了までに13億米ドルに達すると予測されます。結石破砕装置セグメントの成長率は、分析期間中CAGR 4.3％と推定されます。

米国市場は4億4,660万米ドル、中国はCAGR8.1％で成長予測

米国の腎臓結石管理機器市場は、2023年に4億4,660万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 8.1%で推移し、2030年には4億9,450万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.4%と3.9%と予測されています。欧州では、ドイツがCAGR 3.1%で成長すると予測されています。

腎臓結石管理機器-主要動向と促進要因

腎臓結石管理機器は、世界中で数百万人が罹患している一般的な泌尿器科疾患である腎臓結石を診断、治療、管理するために設計された専門医療機器です。これらの機器には、体外衝撃波結石破砕装置（ESWL）、尿管鏡、腎鏡、レーザー結石破砕装置、ステントなど、さまざまな技術や器具が含まれます。ESWL装置は衝撃波で腎結石を細かく砕き、自然に通過できるようにします。尿管鏡と腎鏡は、それぞれ尿路と腎臓内の結石を直接可視化して除去できる内視鏡機器です。レーザー結石破砕装置は、レーザーエネルギーを利用して結石を破砕するもので、高精度で低侵襲な治療法です。ステントは、結石の除去または破砕後の尿の流れを確保し、合併症を予防し、回復を助けるために使用されます。これらの器具は、腎結石の大きさ、位置、成分に合わせた効果的な治療法を提供する上で非常に重要です。

医療技術の進歩や患者ケアのアプローチの変化を反映して、腎臓結石管理機器市場はいくつかの動向によって形成されています。重要な動向のひとつは、回復時間の短縮や合併症発生率の低下に対する患者の要望から、低侵襲手術の採用が増加していることです。このため、最小限の不快感で正確かつ効率的な結石除去を可能にする、軟性尿管鏡やレーザー砕石器の使用が増加しています。技術の進歩もESWL装置の能力を高め、その精度と効果を向上させています。超音波検査や透視検査などの画像技術を結石管理機器に統合することで、結石の視覚化と標的の絞り込みが可能になることも、注目すべき動向です。さらに、食生活や肥満などのライフスタイル要因もあって腎臓結石の有病率が上昇していることも、高度な管理ソリューションの需要を押し上げています。さらに、ステント設計の革新により、ステントに関連する不快感や合併症が減少し、患者の転帰が改善されつつあります。

腎臓結石管理機器市場の成長は、いくつかの要因によってもたらされています。技術の進歩により、結石除去処置の精度、効率、安全性が向上し、より幅広い患者にとってより利用しやすく効果的なものとなっています。食生活の変化、脱水、座りっぱなしの生活スタイルに後押しされた腎臓結石の有病率の増加は、効果的な管理ソリューションの必要性を拡大しています。加えて、腎結石症に対する認識の高まりと高度な治療オプションの利用可能性により、より多くの患者がタイムリーな医療介入を求めるようになっています。また、低侵襲手術の動向も大きな推進力となっています。こうした手術は痛みの軽減、入院期間の短縮、回復時間の短縮をもたらすからです。ヘルスケアプロバイダーは、患者のケアと治療成績の向上のために、こうした先進的な機器を採用するようになってきています。さらに、携帯可能で使い勝手の良い機器の開発により、外来患者や後進地域でも腎結石管理がより身近なものとなっています。腎結石治療に対する政府の支援と有利な償還政策が、市場の成長をさらに後押ししています。全体として、これらの要因が腎臓結石管理機器市場の堅調な成長を促進し、効果的かつ効率的な治療オプションに対する需要の高まりに応えています。

調査対象企業の例（全48件）

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6467

Global Kidney Stone Management Devices Market to Reach US$2.3 Billion by 2030

The global market for Kidney Stone Management Devices estimated at US$1.7 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Lithotripsy segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$446.6 Million While China is Forecast to Grow at 8.1% CAGR

The Kidney Stone Management Devices market in the U.S. is estimated at US$446.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$494.5 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Kidney Stone Management Devices - Key Trends and Drivers

Kidney stone management devices are specialized medical tools designed to diagnose, treat, and manage kidney stones, a common urological condition affecting millions worldwide. These devices encompass a range of technologies and instruments, including extracorporeal shock wave lithotripsy (ESWL) machines, ureteroscopes, nephroscopes, laser lithotripters, and stents. ESWL machines use shock waves to break down kidney stones into smaller fragments that can be passed naturally. Ureteroscopes and nephroscopes are endoscopic devices that allow for the direct visualization and removal of stones within the urinary tract and kidney, respectively. Laser lithotripters utilize laser energy to fragment stones, offering a minimally invasive solution with high precision. Stents are used to ensure the free flow of urine after the removal or fragmentation of stones, preventing complications and aiding recovery. These devices are critical in providing effective treatment options tailored to the size, location, and composition of kidney stones.

Several trends are shaping the kidney stone management devices market, reflecting advancements in medical technology and changes in patient care approaches. One significant trend is the increasing adoption of minimally invasive procedures, driven by patient demand for reduced recovery times and lower complication rates. This has led to the growing use of flexible ureteroscopes and laser lithotripters, which allow for precise and efficient stone removal with minimal discomfort. Technological advancements are also enhancing the capabilities of ESWL machines, improving their accuracy and effectiveness. The integration of imaging technologies, such as ultrasound and fluoroscopy, with stone management devices is another notable trend, enabling better visualization and targeting of stones. Additionally, the rise in the prevalence of kidney stones, partly due to lifestyle factors such as diet and obesity, is driving the demand for advanced management solutions. Furthermore, innovations in stent design are improving patient outcomes by reducing stent-related discomfort and complications.

The growth in the kidney stone management devices market is driven by several factors. Technological advancements are enhancing the precision, efficiency, and safety of stone removal procedures, making them more accessible and effective for a broader range of patients. The increasing prevalence of kidney stones, fueled by dietary changes, dehydration, and sedentary lifestyles, is expanding the need for effective management solutions. Additionally, the growing awareness of kidney stone disease and the availability of advanced treatment options are encouraging more patients to seek timely medical intervention. The trend towards minimally invasive surgeries is also a significant driver, as these procedures offer reduced pain, shorter hospital stays, and quicker recovery times. Healthcare providers are increasingly adopting these advanced devices to improve patient care and outcomes. Moreover, the development of portable and user-friendly devices is making kidney stone management more accessible in outpatient settings and less developed regions. Government support and favorable reimbursement policies for kidney stone treatments are further propelling market growth. Overall, these factors are fostering robust growth in the kidney stone management devices market, meeting the rising demand for effective and efficient treatment options.

Select Competitors (Total 48 Featured) -

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Kidney Stone Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Kidney Stones Drives Demand for Advanced Management Solutions
    • Increasing Adoption of Minimally Invasive Procedures Propels Growth in Kidney Stone Management Devices
    • Technological Advancements in ESWL Machines Strengthen Business Case for Non-Invasive Treatments
    • Integration of Imaging Technologies Expands Addressable Market Opportunity for Precision Stone Removal
    • Innovations in Stent Design Here's How They Improve Patient Outcomes and Reduce Complications
    • Lifestyle Factors Such as Diet and Obesity Spur Growth in Kidney Stone Management Market
    • Growing Awareness of Kidney Stone Disease Generates Demand for Timely Medical Interventions
    • Development of Flexible Ureteroscopes Drives Adoption of Efficient Stone Removal Techniques
    • Increasing Use of Laser Lithotripters: Here's the Story for Precision and Minimal Discomfort in Stone Management
    • Trend towards Outpatient Procedures Expands Market Reach for Portable and User-Friendly Devices
    • Advances in Endoscopic Technologies Spur Growth in Efficient and Effective Stone Removal Solutions
    • Consumer Demand for Reduced Recovery Times and Lower Complication Rates Drives Minimally Invasive Techniques
    • Expansion of Urology Clinics and Specialized Healthcare Centers Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Kidney Stone Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ureteroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Kidney Stone Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Kidney Stone Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION